RDHL Redhill Biopharma Ltd.
$0.45▲ +7.74%
Healthcare
Other
After hours
$0.43▼ -4.64%
Oct 27, 4:53 PM ET
Volume 109.1K
Avg Volume (10D) 137.6K
Key Metrics & Fundamentals
Market Cap
$3.98M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.39 - 1.60
% vs 50 MA
-21.22%
% vs 200 MA
-45.57%
RSI-14
41.0
MACD Histogram
+0.0000
Beta (1Y vs SPY)
0.68
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
$2.9 Million NCI Grant Awarded for Clinical Development of RedHill's Opaganib and CAR T-Cell Combination in Ultra-High-Risk Multiple Myeloma
PR Newswire · Oct 19, 2026 8:00 AM ET
Weekly Losses Deepen As Small Caps Lag And Yields Edge Higher Into Earnings Gauntlet
CNW Group · Oct 1, 2026 3:12 PM ET
RedHill Biopharma Announces Operational Highlights and First Half 2026 Financial Results
PR Newswire · Sep 30, 2026 4:05 PM ET
RedHill (RDHL) Acquires Rebyota and Clenpiq Commercialization Rights for $12M Upfront. Can Sales Outpace Royalties?
Insider Monkey · Sep 10, 2026 12:06 PM ET
RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring's Rebyota® and Clenpiq®
PR Newswire · Sep 1, 2026 7:00 AM ET
RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring’s Rebyota® and Clenpiq®
GlobeNewswire · Sep 1, 2026 7:00 AM ET
Nontuberculous Mycobacterial Infections Market to Showcase Growth at a CAGR of 12.6% During the Forecast Period (2026–2036), Driven by Rising Disease Burden and Emerging Therapies | DelveInsight
GlobeNewswire · Aug 31, 2026 1:00 PM ET
Redhill Biopharma Stock Doubles In One Session — Here's Why
Benzinga · Aug 31, 2026 10:06 AM ET
RedHill Divests Talicia® to Apotex for $18 Million Cash Upfront Plus Milestones to Fuel Strategic Growth Opportunities
CNW Group · Aug 31, 2026 7:00 AM ET
RedHill Divests Talicia® to Apotex for $18 Million Cash Upfront Plus Milestones to Fuel Strategic Growth Opportunities
PR Newswire · Aug 31, 2026 7:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.